Contract Development Manufacturing Organizations Market Size Projected To Increase From $309.9 Billion To $503.82 Billion During The Forecast Period
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Contract Development Manufacturing Organizations Market Forecast Highlighting Growth From $309.9 Billion To $503.82 Billion
The market for contract development and manufacturing organizations has seen swift expansion in recent years. Its value is projected to increase from $274.79 billion in 2025 to $309.9 billion in 2026, reflecting a compound annual growth rate of 12.8%. The historical growth has been driven by factors such as cost savings achieved through outsourcing, a surge in pharmaceutical research and development spending, a rise in generic drug manufacturing, heightened regulatory hurdles, and constrained internal production capabilities.
Over the coming years, the market for contract development and manufacturing organizations is set to experience strong expansion. By 2030, its value is projected to hit $503.82 billion, expanding at a compound annual growth rate (CAGR) of 12.9%. Several factors are driving this anticipated growth, such as the expansion of biologics and advanced therapeutic modalities, a rising need for adaptable manufacturing capabilities, the growth of smaller and mid-sized pharmaceutical firms, a higher volume of clinical trials, and an expanding global pharmaceutical development pipeline. Key developments shaping the forecast period involve a greater reliance on outsourcing for drug development and manufacturing, heightened demand for integrated CDMO solutions, broadening capacities for biologics and biosimilars production, an increased emphasis on meeting regulatory standards and ensuring quality, and strategic capacity improvements worldwide.
Download A Free Sample Report For Comprehensive Market Insights:
Contract Development Manufacturing Organizations Market Opportunity Drivers: What Is Creating New Revenue Potential?
An increasing need for pharmaceutical products, fueled by the rise in chronic illnesses and an aging population, has significantly boosted the contract development and manufacturing organization (CDMO) market. Because chronic diseases and elderly demographics are on the rise, pharmaceutical firms have accelerated their production of biologics and biosimilars; consequently, many have chosen to outsource their tasks, operations, and testing to contract manufacturing organizations that operate on a contractual basis. For example, data released in November 2023 by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade association based in Belgium, indicates that total pharmaceutical production in Europe reached €390 billion ($422.8 billion) in 2023, compared to €363.3 billion ($393.9 billion) in 2022. As a result, this growing demand for pharmaceutical products is propelling the expansion of the contract development manufacturing organization market.
Contract Development Manufacturing Organizations Market Segment Analysis And Revenue Opportunities
The contract development manufacturing organizations market covered in this report is segmented –
1) By Service: CMO, CRO
2) By Product: Small Molecules, Biologics
3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users
Subsegments:
1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services
2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs Consulting
Contract Development Manufacturing Organizations Market Innovation Trends Driving Future Development
Major players in the contract development and manufacturing organization market are driving revenue growth through innovative initiatives like Lifera, a commercial-scale CDMO. In June 2023, the Public Investment Fund (PIF), Saudi Arabia’s global investment entity, launched Lifera. This company will concentrate on producing critical biopharmaceutical products, including insulin, vaccines, monoclonal antibodies, plasma treatments, cell and gene therapies, and advanced small molecules. To strengthen local capabilities and foster domestic manufacturing within this sector, Lifera intends to collaborate with leading local and international firms, while also attracting targeted investments. Key goals for Lifera encompass driving formulation development, drug development, and manufacturing activities.
Contract Development Manufacturing Organizations Market Leading Players Shaping Industry Direction
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
Access The Complete Contract Development Manufacturing Organizations Market Report:
Contract Development Manufacturing Organizations Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
